ID   PAPD1_HUMAN             Reviewed;         582 AA.
AC   Q9NVV4; D3DRX0; Q659E3; Q6P7E5; Q9HA74;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 133.
DE   RecName: Full=Poly(A) RNA polymerase, mitochondrial;
DE            Short=PAP;
DE            EC=2.7.7.19 {ECO:0000269|PubMed:20970105, ECO:0000269|PubMed:21292163};
DE   AltName: Full=PAP-associated domain-containing protein 1;
DE   AltName: Full=Polynucleotide adenylyltransferase;
DE   AltName: Full=Terminal uridylyltransferase 1;
DE            Short=TUTase 1;
DE   AltName: Full=mtPAP;
DE   Flags: Precursor;
GN   Name=MTPAP; Synonyms=PAPD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15547249; DOI=10.1093/nar/gkh923;
RA   Tomecki R., Dmochowska A., Gewartowski K., Dziembowski A.,
RA   Stepien P.P.;
RT   "Identification of a novel human nuclear-encoded mitochondrial poly(A)
RT   polymerase.";
RL   Nucleic Acids Res. 32:6001-6014(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15769737; DOI=10.1074/jbc.M500804200;
RA   Nagaike T., Suzuki T., Katoh T., Ueda T.;
RT   "Human mitochondrial mRNAs are stabilized with polyadenylation
RT   regulated by mitochondria-specific poly(A) polymerase and
RT   polynucleotide phosphorylase.";
RL   J. Biol. Chem. 280:19721-19727(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16533400; DOI=10.1186/1471-2164-7-48;
RA   Kemmer D., Podowski R.M., Arenillas D., Lim J., Hodges E., Roth P.,
RA   Sonnhammer E.L.L., Hoeoeg C., Wasserman W.W.;
RT   "NovelFam3000 -- uncharacterized human protein domains conserved
RT   across model organisms.";
RL   BMC Genomics 7:48-48(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   HIS-221; ARG-419 AND ASN-546.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION IN HISTONE MRNA DEGRADATION ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18172165; DOI=10.1101/gad.1622708;
RA   Mullen T.E., Marzluff W.F.;
RT   "Degradation of histone mRNA requires oligouridylation followed by
RT   decapping and simultaneous degradation of the mRNA both 5' to 3' and
RT   3' to 5'.";
RL   Genes Dev. 22:50-65(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-90, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 44-538, FUNCTION, CATALYTIC
RP   ACTIVITY, SUBUNIT, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF 221-TYR-PHE-222; PHE-230; 259-HIS--ILE-261;
RP   294-HIS--PRO-297; LEU-312; ASP-325 AND PHE-378.
RX   PubMed=21292163; DOI=10.1016/j.molcel.2011.01.013;
RA   Bai Y., Srivastava S.K., Chang J.H., Manley J.L., Tong L.;
RT   "Structural basis for dimerization and activity of human PAPD1, a
RT   noncanonical poly(A) polymerase.";
RL   Mol. Cell 41:311-320(2011).
RN   [13]
RP   VARIANT SPAX4 ASP-478, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=20970105; DOI=10.1016/j.ajhg.2010.09.013;
RA   Crosby A.H., Patel H., Chioza B.A., Proukakis C., Gurtz K.,
RA   Patton M.A., Sharifi R., Harlalka G., Simpson M.A., Dick K.,
RA   Reed J.A., Al-Memar A., Chrzanowska-Lightowlers Z.M., Cross H.E.,
RA   Lightowlers R.N.;
RT   "Defective mitochondrial mRNA maturation is associated with spastic
RT   ataxia.";
RL   Am. J. Hum. Genet. 87:655-660(2010).
CC   -!- FUNCTION: Polymerase that creates the 3' poly(A) tail of
CC       mitochondrial transcripts. Can use all four nucleotides, but has
CC       higher activity with ATP and UTP (in vitro). Plays a role in
CC       replication-dependent histone mRNA degradation. May be involved in
CC       the terminal uridylation of mature histone mRNAs before their
CC       degradation is initiated. Might be responsible for the creation of
CC       some UAA stop codons which are not encoded in mtDNA.
CC       {ECO:0000269|PubMed:15547249, ECO:0000269|PubMed:15769737,
CC       ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:20970105,
CC       ECO:0000269|PubMed:21292163}.
CC   -!- CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1).
CC       {ECO:0000269|PubMed:20970105, ECO:0000269|PubMed:21292163}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:21292163};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:21292163};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.1 mM for ATP {ECO:0000269|PubMed:21292163};
CC         KM=0.7 mM for UTP {ECO:0000269|PubMed:21292163};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:21292163}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-2556166, EBI-2556166;
CC       Q9QYP6:Azi2 (xeno); NbExp=2; IntAct=EBI-2556166, EBI-6115874;
CC       Q13137:CALCOCO2; NbExp=2; IntAct=EBI-2556166, EBI-739580;
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-2556166, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18172165}.
CC       Mitochondrion {ECO:0000269|PubMed:15547249,
CC       ECO:0000269|PubMed:15769737}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NVV4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NVV4-2; Sequence=VSP_020724;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with stronger expression in
CC       tissues with high energy requirements: heart, brain, and skeletal
CC       muscle. {ECO:0000269|PubMed:15547249}.
CC   -!- DISEASE: Spastic ataxia 4, autosomal recessive (SPAX4)
CC       [MIM:613672]: A slowly progressive neurodegenerative disease
CC       characterized by cerebellar ataxia, spastic paraparesis,
CC       dysarthria, and optic atrophy. {ECO:0000269|PubMed:20970105}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry. MTPAP mutations result in a defect of
CC       mitochondrial mRNA maturation. Affected individuals exhibit a
CC       drastic decrease in poly(A) tail length of mitochondrial mRNA
CC       transcripts, including COX1 and RNA14 (PubMed:20970105).
CC       {ECO:0000269|PubMed:20970105}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B-like family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB194709; BAD98252.1; -; mRNA.
DR   EMBL; AY364242; AAQ76801.1; -; mRNA.
DR   EMBL; AK001348; BAA91641.1; -; mRNA.
DR   EMBL; AK022188; BAB13981.1; -; mRNA.
DR   EMBL; AL122121; CAH56395.1; -; mRNA.
DR   EMBL; AL353796; CAH72262.1; -; Genomic_DNA.
DR   EMBL; AL161651; CAH72262.1; JOINED; Genomic_DNA.
DR   EMBL; AL161651; CAI14218.1; -; Genomic_DNA.
DR   EMBL; AL353796; CAI14218.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86014.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86015.1; -; Genomic_DNA.
DR   EMBL; BC061703; AAH61703.1; -; mRNA.
DR   CCDS; CCDS7165.1; -. [Q9NVV4-1]
DR   RefSeq; NP_060579.3; NM_018109.3. [Q9NVV4-1]
DR   UniGene; Hs.173946; -.
DR   PDB; 3PQ1; X-ray; 3.10 A; A/B=44-134, A/B=172-452, A/B=490-538.
DR   PDBsum; 3PQ1; -.
DR   ProteinModelPortal; Q9NVV4; -.
DR   SMR; Q9NVV4; -.
DR   BioGrid; 120452; 23.
DR   IntAct; Q9NVV4; 13.
DR   MINT; MINT-4831364; -.
DR   STRING; 9606.ENSP00000263063; -.
DR   iPTMnet; Q9NVV4; -.
DR   PhosphoSitePlus; Q9NVV4; -.
DR   SwissPalm; Q9NVV4; -.
DR   BioMuta; MTPAP; -.
DR   DMDM; 74753002; -.
DR   EPD; Q9NVV4; -.
DR   MaxQB; Q9NVV4; -.
DR   PaxDb; Q9NVV4; -.
DR   PeptideAtlas; Q9NVV4; -.
DR   PRIDE; Q9NVV4; -.
DR   Ensembl; ENST00000263063; ENSP00000263063; ENSG00000107951. [Q9NVV4-1]
DR   GeneID; 55149; -.
DR   KEGG; hsa:55149; -.
DR   UCSC; uc001iva.5; human. [Q9NVV4-1]
DR   CTD; 55149; -.
DR   DisGeNET; 55149; -.
DR   GeneCards; MIR7162; -.
DR   GeneCards; MTPAP; -.
DR   HGNC; HGNC:25532; MTPAP.
DR   HPA; HPA038620; -.
DR   HPA; HPA058232; -.
DR   MalaCards; MTPAP; -.
DR   MIM; 613669; gene.
DR   MIM; 613672; phenotype.
DR   neXtProt; NX_Q9NVV4; -.
DR   OpenTargets; ENSG00000107951; -.
DR   Orphanet; 254343; Autosomal recessive spastic ataxia - optic atrophy - dysarthria.
DR   PharmGKB; PA164723192; -.
DR   eggNOG; KOG2277; Eukaryota.
DR   eggNOG; COG5260; LUCA.
DR   GeneTree; ENSGT00550000074490; -.
DR   HOGENOM; HOG000115438; -.
DR   HOVERGEN; HBG082104; -.
DR   InParanoid; Q9NVV4; -.
DR   KO; K18060; -.
DR   OMA; THKTSGN; -.
DR   OrthoDB; EOG091G091J; -.
DR   PhylomeDB; Q9NVV4; -.
DR   TreeFam; TF354308; -.
DR   BRENDA; 2.7.7.19; 2681.
DR   ChiTaRS; MTPAP; human.
DR   EvolutionaryTrace; Q9NVV4; -.
DR   GenomeRNAi; 55149; -.
DR   PRO; PR:Q9NVV4; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107951; -.
DR   ExpressionAtlas; Q9NVV4; baseline and differential.
DR   Genevisible; Q9NVV4; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0002134; F:UTP binding; IDA:UniProtKB.
DR   GO; GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR002058; PAP_assoc.
DR   Pfam; PF03828; PAP_assoc; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Disease mutation; Magnesium; Manganese;
KW   Metal-binding; Mitochondrion; mRNA processing; Neurodegeneration;
KW   Nucleotide-binding; Nucleotidyltransferase; Polymorphism;
KW   Reference proteome; RNA-binding; Transcription; Transferase;
KW   Transit peptide.
FT   TRANSIT       1     37       Mitochondrion. {ECO:0000255}.
FT   CHAIN        38    582       Poly(A) RNA polymerase, mitochondrial.
FT                                /FTId=PRO_0000250689.
FT   DOMAIN      437    483       PAP-associated.
FT   NP_BIND     107    109       ATP. {ECO:0000255}.
FT   NP_BIND     241    242       ATP. {ECO:0000255}.
FT   METAL       243    243       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   METAL       245    245       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   MOD_RES      90     90       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     52       MAVPGVGLLTRLNLCARRRTRVQRPIVRLLSCPGTVAKDLR
FT                                RDEQPSGSVET -> MAWAKKVGGRAGQGRSLSRCDPIILD
FT                                PEWLYGPPEGEGGPEGVGGETRASIHPPLRTGRHHQKVNHN
FT                                IRGPEGSAKDAAPGGGGHHQAGPGQRGDEDGALQHLCGGGG
FT                                GVGVSVGRGTGTSVAAEHPSLQVKLLELQELVLRLAGDHNE
FT                                GHGKFLAAAQNPADDPAPGAPAPQELGAADKQG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_020724.
FT   VARIANT     162    162       R -> C (in dbSNP:rs1047991).
FT                                /FTId=VAR_027601.
FT   VARIANT     221    221       Y -> H (in dbSNP:rs17855118).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027602.
FT   VARIANT     419    419       C -> R (in dbSNP:rs17857517).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027603.
FT   VARIANT     478    478       N -> D (in SPAX4; dbSNP:rs267606900).
FT                                {ECO:0000269|PubMed:20970105}.
FT                                /FTId=VAR_064907.
FT   VARIANT     546    546       S -> N (in dbSNP:rs17855116).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027604.
FT   MUTAGEN     221    222       YF->AA: Reduces dimerization.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     230    230       F->A: Reduced enzyme activity.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     259    261       HKI->AAA: No effect on dimerization. Loss
FT                                of dimerization and of enzyme activity;
FT                                when associated with 294-AAAA-297.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     294    297       HFGP->AAGA: Reduced dimerization. Loss of
FT                                dimerization and of enzyme activity; when
FT                                associated with 259-AAA-261.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     312    312       L->A: Reduced enzyme activity.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     325    325       D->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:21292163}.
FT   MUTAGEN     378    378       F->A: Reduced enzyme activity.
FT                                {ECO:0000269|PubMed:21292163}.
FT   CONFLICT    507    507       W -> L (in Ref. 4; BAB13981).
FT                                {ECO:0000305}.
FT   CONFLICT    554    554       V -> A (in Ref. 4; BAB13981).
FT                                {ECO:0000305}.
FT   HELIX        64     75       {ECO:0000244|PDB:3PQ1}.
FT   STRAND       77     82       {ECO:0000244|PDB:3PQ1}.
FT   HELIX        90     95       {ECO:0000244|PDB:3PQ1}.
FT   HELIX        96     98       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      104    107       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      109    117       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       125    128       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       174    180       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      183    185       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       186    197       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       201    218       {ECO:0000244|PDB:3PQ1}.
FT   TURN        219    221       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      226    230       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       231    233       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      244    249       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       277    294       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      299    305       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      307    310       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      312    317       {ECO:0000244|PDB:3PQ1}.
FT   TURN        318    320       {ECO:0000244|PDB:3PQ1}.
FT   STRAND      323    327       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       333    344       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       348    363       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       377    389       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       403    406       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       437    447       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       448    450       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       492    510       {ECO:0000244|PDB:3PQ1}.
FT   HELIX       528    530       {ECO:0000244|PDB:3PQ1}.
SQ   SEQUENCE   582 AA;  66172 MW;  EBA5BECEA39A5090 CRC64;
     MAVPGVGLLT RLNLCARRRT RVQRPIVRLL SCPGTVAKDL RRDEQPSGSV ETGFEDKIPK
     RRFSEMQNER REQAQRTVLI HCPEKISENK FLKYLSQFGP INNHFFYESF GLYAVVEFCQ
     KESIGSLQNG THTPSTAMET AIPFRSRFFN LKLKNQTSER SRVRSSNQLP RSNKQLFELL
     CYAESIDDQL NTLLKEFQLT EENTKLRYLT CSLIEDMAAA YFPDCIVRPF GSSVNTFGKL
     GCDLDMFLDL DETRNLSAHK ISGNFLMEFQ VKNVPSERIA TQKILSVLGE CLDHFGPGCV
     GVQKILNARC PLVRFSHQAS GFQCDLTTNN RIALTSSELL YIYGALDSRV RALVFSVRCW
     ARAHSLTSSI PGAWITNFSL TMMVIFFLQR RSPPILPTLD SLKTLADAED KCVIEGNNCT
     FVRDLSRIKP SQNTETLELL LKEFFEYFGN FAFDKNSINI RQGREQNKPD SSPLYIQNPF
     ETSLNISKNV SQSQLQKFVD LARESAWILQ QEDTDRPSIS SNRPWGLVSL LLPSAPNRKS
     FTKKKSNKFA IETVKNLLES LKGNRTENFT KTSGKRTIST QT
//
